Afinitor®
Advanced neuroendocrine tumors of pancreatic origin (pNET)
AFINITOR is indicated for the treatment of unresectable or metastatic, well-or moderately-differentiated neuroendocrine tumours of pancreatic origin in adults with progressive disease.
This information is based on the European Summary of Product Characteristics. The prescribing information in your country may vary; please consult your local prescribing information and/or contact your local Novartis representative.
www.afinitor.com/global »
(For Non U.S. Health Care Professionals Only)
www.afinitor.com/advanced-renal-cell-carcinoma/hcp/index.jsp »
(For U.S. Health Care Professionals Only)
www.afinitor.com »
(For U.S. Residents Only)